Literature DB >> 26183532

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?

D Benedetti1, E Tissino1, C Caldana1, M Dal Bo1, R Bomben1, D Marconi1, S Ganghammer2, F Zaja3, G Pozzato4, F Di Raimondo5, T N Hartmann2, G Del Poeta6, A VanMeter7, A Zucchetto1, V Espina7, L Liotta7, V Gattei1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26183532     DOI: 10.1038/leu.2015.149

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.

Authors:  A Zucchetto; T Vaisitti; D Benedetti; E Tissino; V Bertagnolo; D Rossi; R Bomben; M Dal Bo; M I Del Principe; A Gorgone; G Pozzato; G Gaidano; G Del Poeta; F Malavasi; S Deaglio; V Gattei
Journal:  Leukemia       Date:  2012-01-06       Impact factor: 11.528

2.  Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

Authors:  J A Burger; M Burger; T J Kipps
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

Review 3.  Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.

Authors:  Adrian Wiestner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

4.  Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors.

Authors:  Antonella Chiechi; Chiara Novello; Giovanna Magagnoli; Emanuel F Petricoin; Jianghong Deng; Maria S Benassi; Piero Picci; Iosif Vaisman; Virginia Espina; Lance A Liotta
Journal:  Clin Cancer Res       Date:  2013-03-14       Impact factor: 12.531

5.  Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.

Authors:  Amit K Mittal; Nagendra K Chaturvedi; Karan J Rai; Christine E Gilling-Cutucache; Tara M Nordgren; Margaret Moragues; Runqing Lu; Rene Opavsky; Greg R Bociek; Dennis D Weisenburger; Javeed Iqbal; Shantaram S Joshi
Journal:  Mol Med       Date:  2014-07-15       Impact factor: 6.354

6.  Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Authors:  Valter Gattei; Pietro Bulian; Maria Ilaria Del Principe; Antonella Zucchetto; Luca Maurillo; Francesco Buccisano; Riccardo Bomben; Michele Dal-Bo; Fabrizio Luciano; Francesca M Rossi; Massimo Degan; Sergio Amadori; Giovanni Del Poeta
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

7.  CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.

Authors:  Antonella Zucchetto; Dania Benedetti; Claudio Tripodo; Riccardo Bomben; Michele Dal Bo; Daniela Marconi; Fleur Bossi; Debora Lorenzon; Massimo Degan; Francesca Maria Rossi; Davide Rossi; Pietro Bulian; Vito Franco; Giovanni Del Poeta; Silvia Deaglio; Gianluca Gaidano; Francesco Tedesco; Fabio Malavasi; Valter Gattei
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

8.  CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.

Authors:  Pietro Bulian; Tait D Shanafelt; Chris Fegan; Antonella Zucchetto; Lilla Cro; Holger Nückel; Luca Baldini; Antonina V Kurtova; Alessandra Ferrajoli; Jan A Burger; Gianluca Gaidano; Giovanni Del Poeta; Chris Pepper; Davide Rossi; Valter Gattei
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

Review 9.  Integrin-linked kinase: integrin's mysterious partner.

Authors:  Carsten Grashoff; Ingo Thievessen; Katrin Lorenz; Siegfried Ussar; Reinhard Fässler
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

Review 10.  Application of molecular technologies for phosphoproteomic analysis of clinical samples.

Authors:  M Pierobon; J Wulfkuhle; L Liotta; E Petricoin
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

View more
  1 in total

Review 1.  Molecular Players in Hematologic Tumor Cell Trafficking.

Authors:  Javier Redondo-Muñoz; Angeles García-Pardo; Joaquin Teixidó
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.